FDA Drug Recalls

Recalls / Class II

Class IID-0260-2015

Product

Methyl B12 25 mg/mL Inj., 10 Syringes, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-2014-37

Affected lot / code info
141006GG, 11/6/14; 141009FF, 11/9/14; 141014BB, 11/9/14; 141014BB, 11/14/14; 1410164, 11/16/14; 141021GG, 11/21/14; 141030DD, 11/30/14

Why it was recalled

Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Recalling firm

Firm
Perry Drug Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
12200 W 106th St Ste 140, N/A, Overland Park, Kansas 66215-2305

Distribution

Quantity
186 prefilled syringes
Distribution pattern
Kansas and Missouri

Timeline

Recall initiated
2014-11-07
FDA classified
2014-11-24
Posted by FDA
2014-12-03
Terminated
2015-11-03
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0260-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.